CapMedic® is an FDA-cleared Class II patented medical device. It captures physiologic measures of lung function and inhalation parameters.
NHLBI traffic-light comparison with personal best.
NHLBI traffic-light comparison with personal best.
*Data from Paronyan et al. ’20, Landon et al. ’20
GINA guidelines recommend a 2-month visualization of FEV1, PEF to allow accurate identification of worsening asthma.
Summary charts to simplify the data than looking at numbers.
Cognita provides remote installation and onboarding including:
Patients perform PFTs, get daily feedback on inhaler use.
Automatical data sync over wifi/cellular network.
Cognita’s care team also performs:
See a live demo of the full RPM solution with CapMedic and implementation workflow for your practice. Fill the form out below and we will get in touch with you at your preferred time. Don’t worry, we don’t spam and you can unsubscribe at any time.
© 2022 Cognita Labs, LLC All Rights Reserved. CapMedic is a registered trademark of Cognita Labs, LLC. 700 N Main St. Ste C1 Santa Ana CA 92701
VENTOLIN®, ADVAIR®, and FLOVENT® are registered trademarks of the GSK group of companies. PROVENTIL®, ASMANEX®, and DULERA® are registered trademarks of Merck Sharp & Dohme Corp. Endo International plc. PROAIR® is a registered trademark of Teva Respiratory, LLC. ALVESCO® is a registered trademark of Takeda GmbH. XOPENEX® is a registered trademark of Sunovion Pharmaceuticals Inc. ATROVENT® is a trademark of Boehringer Ingelheim International GmbH. SYMBICORT® is a trademark of AstraZeneca AB.